Identification of hepatic tamoxifen-DNA adducts in mice:: α-(N2-deoxyguanosinyl)tamoxifen and α-(N2-deoxyguanosinyl)tamoxifen N-oxide

被引:25
作者
Umemoto, A
Monden, Y
Suwa, M
Kanno, Y
Suzuki, M
Lin, CX
Ueyama, Y
Momen, MA
Ravindernath, A
Shibutani, S
Komaki, K
机构
[1] Univ Tokushima, Sch Med, Dept Surg 2, Tokushima 7708503, Japan
[2] Nippon Kayaku Co Ltd, Pharmaceut Grp, Kita Ku, Tokyo 1158588, Japan
[3] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA
关键词
D O I
10.1093/carcin/21.9.1737
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tamoxifen-DNA adducts detected in the liver of mice treated with tamoxifen have not yet been identified. In the present study a new type of tamoxifen-DNA adduct, four stereoisomers of alpha-(N-2-deoxyguanosinyl)tamoxifen N-oxide 3'-monophosphate (dG(3'P)-N-2-TAM N-oxide) were prepared as standard DNA adducts by reacting 2'-deoxyguanosine 3'-monophosphate with trans-alpha-acetoxytamoxifen N-oxide in addition to four stereoisomers of alpha-(N2-deoxyguanosinyl)tamoxifen 3'-monophosphate (dG(3'P)-N-2-TAM) that was reported previously, Liquid chromatography-electrospray ionization-mass spectrometry of the reaction products gave the most abundant ion at m/z 731 ([M - H](-)), which corresponded to dG(3'P)-N-2-TAM N-oxide, The modified products digested by alkaline phosphatase corresponded to the isomers of dG-N-2-TAM N-oxide whose structures were identified previously by mass spectrometry and nuclear magnetic resonance. Using these standard markers, we analyzed the hepatic DNA adducts of female DBA/2 mice treated with tamoxifen at a dosage of 120 mg/ kg/day for 7 days by P-32-post-labeling coupled with an HPLC/radioactive detector. Mixtures of eight isomers of dG(3'P)-N-2-TAM and dG(3'P)-N-2-TAM N-oxide were separated into six peaks, since each of the cis epimers were not separated under the present HPLC conditions. Nine adducts were detected in all liver samples of mice. An epimer of trans-dG(3'P)-N-2-TAM was detected as the principal DNA adduct at a level of 29.0 adducts/10(8) nucleotides, which accounted for 53.3% of the total tamoxifen-DNA adducts, Lesser amounts of cis-dG(3'P)-N-2-TAM (2.8%) were also observed. An epimer of the trans-dG(3'P)-N-2-TAM N-oxide (3.9 adducts/10(8) nucleotides) was detected as the third biggest adduct (7.2% of the total). The Cis-dG(3'P)-N-2-TAM N-oxide (0.4 adducts/10(8) nucleotides) accounted for 0.7% of the total. Thus, dG(3'P)-N-2-TAM and dG(3'P)-N-2-TAM N-oxide were identified in tamoxifen-treated mouse liver.
引用
收藏
页码:1737 / 1744
页数:8
相关论文
共 41 条
[1]   Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo [J].
Beland, FA ;
McDaniel, LP ;
Marques, MM .
CARCINOGENESIS, 1999, 20 (03) :471-477
[2]   Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N,N-didesmethyltamoxifen [J].
Brown, K ;
Heydon, RT ;
Jukes, R ;
White, INH ;
Martin, EA .
CARCINOGENESIS, 1999, 20 (10) :2011-2016
[3]   Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen [J].
Dasaradhi, L ;
Shibutani, S .
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (02) :189-196
[4]   The metabolic activation of tamoxifen and α-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation [J].
Davis, W ;
Venitt, S ;
Phillips, DH .
CARCINOGENESIS, 1998, 19 (05) :861-866
[5]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388
[6]   ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14 [J].
FISHER, B ;
COSTANTINO, JP ;
REDMOND, CK ;
FISHER, ER ;
WICKERHAM, DL ;
CRONIN, WM ;
BOWMAN, D ;
COUTURE, J ;
DIMITROV, NV ;
EVANS, J ;
FARRAR, W ;
KAVANAH, M ;
LICKLEY, HL ;
MARGOLESE, R ;
PATERSON, AHG ;
ROBIDOUX, A ;
SHIBATA, H ;
TERZ, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07) :527-537
[7]  
GREAVES P, 1993, CANCER RES, V53, P3919
[8]  
HARD GC, 1993, CANCER RES, V53, P4534
[9]   Interspecies differences in cancer susceptibility and toxicity [J].
Hengstler, JG ;
Van der Burg, B ;
Steinberg, P ;
Oesch, F .
DRUG METABOLISM REVIEWS, 1999, 31 (04) :917-970
[10]  
*IARC, 1996, IARC SCI PUBL, V66